C74.1
Conditions
Interventions
Group 1: Patients with neuroblastic tumors are registered at the time of first diagnosis. The treating physicians report key epidemiologic and clinical data to the registry during treatment. After the
Sponsors
UK Köln
Eligibility
Sex/Gender
All
Age
0 Years to No maximum
Inclusion criteria
Inclusion criteria: Diagnosis or suspicion of neuroblastic tumor in patients either histologically or cytologically proven neuroblastic tumors such as neuroblastoma, ganglioneuroblastoma, and ganglioneuroma (at diagnosis or at relapse), also suspected neuroblastoma in newborns and infants (e.g. suprarenal lesions) detected at least during two independent ultrasound investigations, any age, any stage, any MYCN status, written Guardians’ informed consent of parents or legal guardians and / or of the patient’s informed consent if appropriate according to age and status of psycho-intellectual development.
Exclusion criteria
Exclusion criteria: For this registry, no exclusion criteria are defined. Each patient meeting the inclusion criteria given above may be registered.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Aims of the registry are the collection of clinical data, to give the frame for reference diagnostics, and the collection of biomaterial. | — |
Secondary
| Measure | Time frame |
|---|---|
| not relevant | — |
Countries
Germany
Contacts
Public ContactBarbara Hero
UK Köln
Outcome results
None listed